Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc. | SVP, Chief Scientific Officer | Common Stock | 43.7K | $161K | $3.68 | Mar 10, 2022 | Direct |
Aprea Therapeutics, Inc. | SVP, Chief Scientific Officer | Stock Option (right to Buy) | 100K | Mar 10, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APRE | Aprea Therapeutics, Inc. | Mar 10, 2022 | 2 | $0 | 4 | Mar 14, 2022 | SVP, Chief Scientific Officer |
APRE | Aprea Therapeutics, Inc. | Oct 1, 2021 | 3 | -$199K | 4 | Oct 5, 2021 | SVP, Chief Scientific Officer |
APRE | Aprea Therapeutics, Inc. | Sep 20, 2021 | 3 | -$101K | 4 | Sep 22, 2021 | SVP, Chief Scientific Officer |